Top

Published in:

Open Access 01-03-2010

Healthy Colon, Healthy Life (Colon Sano, Vida Sana): Colorectal Cancer Screening Among Latinos in Santa Clara, California

Authors: Judith M. E. Walsh, René Salazar, Celia Kaplan, Lamkieu Nguyen, Jimmy Hwang, Rena J. Pasick

Published in: Journal of Cancer Education | Issue 1/2010

Abstract

Colorectal cancer (CRC) screening rates are low among Latinos. To identify factors associated with CRC screening, we conducted a telephone survey of Latino primary care patients aged 50–79 years. Among 1,013 participants, 38% were up-to-date (UTD) with fecal occult blood test (FOBT); 66% were UTD with any CRC screening (FOBT, sigmoidoscopy, or colonoscopy). Individuals less than 65, females, those less acculturated, and patients of female physicians were more likely to be UTD with FOBT. CRC screening among Latinos is low. Younger patients, women, and patients of female physicians receive more screening.

United States Preventive Services Task Force (2002) Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137(2):129–131

Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and Adenomatous Polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer, and the American College of radiology. CA Cancer J Clin 58(3):130–160CrossRefPubMed

Morbidity and Mortality Weekly Report (2006) Increased use of colorectal cancer tests—United States, 2002 and 2004. MMWR 55(11):308–311

American Cancer Society (2006) Cancer prevention and early detection facts and figures. American Cancer Society, Atlanta, pp 1–60

Walsh J, Kaplan C, Nguyen B, Gildengorin G, McPhee S, Perez-Stable E (2004) Barriers to colorectal cancer screening in Latino and Vietnamese Americans. J Gen Intern Med 19:156–166CrossRefPubMed

Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101(1):3–27CrossRefPubMed

American Cancer Society (2006–2008) Cancer facts & figures for Hispanics/Latinos. American Cancer Society, Atlanta

Salazar R, Walsh J, Gildengorin G, Perez-Stable E (2003) Impacts of beliefs on colorectal cancer screening in Latinos. Paper presented at Society of General Internal Medicine 26th annual meeting

Beach M, Flood A, Robinson C et al (2007) Can language-concordant prevention care managers improve cancer screening rates? Cancer Epidemiol Biomark Prev 16:2058–2064CrossRef

10.

Jo A, Maxwell A, Wong W, Bastani R (2008) Colorectal cancer screening among underserved Korean Americans in Los Angeles County. J Immigr Minor Health 10(2):119–126CrossRefPubMed

11.

Tang TS, Solomon LJ, McCracken LM (2001) Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract 9(6):277–282CrossRefPubMed

12.

Walsh J, McPhee S (1992) A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q 19(2):157–175PubMed

13.

Pasick R, D'Onofrio C, Otero-Sabogal R (1996) Similarities and differences across cultures: questions to inform a third generation for health promotion research. Health Educ Q 23(S):s142–s161

14.

Marin G, Sabogal F (1987) Development of a short acculturation scale for Hispanics. Hisp J Behav Sci 9:183–205CrossRef

15.

SAS 9.1.3. http://www.sas.com/index.html

16.

Shokar NK, Carlson CA, Weller SC (2007) Prevalence of colorectal cancer testing and screening in a multiethnic primary care population. J Community Health 32(5):311–323CrossRefPubMed

17.

Etzioni DA, Ponce NA, Babey SH et al (2004) A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer 101(11):2523–2532CrossRefPubMed

18.

Shah M, Zhu K, Potter J (2006) Hispanic acculturation and utilization of colorectal cancer screening in the United States. Cancer Detect Prev 30(3):306–312CrossRefPubMed

19.

Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K (1993) Preventive care for women. Does the sex of the physician matter? N Engl J Med 329(7):478–482CrossRefPubMed

20.

Cassard SD, Weisman CS, Plichta SB, Johnson TL (1997) Physician gender and women's preventive services. J Women's Health 6(2):199–207CrossRef

21.

Levy S, Dowling P, Boult L, Monroe A, McQuade W (1992) The effect of physician and patient gender on preventive medicine practices in patients older than fifty. Fam Med 24(1):58–61PubMed

22.

Franks P, Clancy CM (1993) Physician gender bias in clinical decisionmaking: screening for cancer in primary care. Med Care 31(3):213–218CrossRefPubMed

23.

Flocke SA, Gilchrist V (2005) Physician and patient gender concordance and the delivery of comprehensive clinical preventive services. Med Care 43(5):486–492CrossRefPubMed

24.

Cooper-Patrick L, Gallo JJ, Gonzales JJ et al (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282(6):583–589CrossRefPubMed

25.

Lin EH (1983) Intraethnic characteristics and the patient-physician interaction: “cultural blind spot syndrome”. J Fam Pract 16(1):91–98PubMed

26.

Kreuter M, Lukwago S, Bucholtz R, Clark E, Sanders-Thompson V (2003) Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches. Health Educ Behav 30(2):133–146CrossRefPubMed

Title: Healthy Colon, Healthy Life (Colon Sano, Vida Sana): Colorectal Cancer Screening Among Latinos in Santa Clara, California
Authors: Judith M. E. Walsh
René Salazar
Celia Kaplan
Lamkieu Nguyen
Jimmy Hwang
Rena J. Pasick
Publication date: 01-03-2010
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 1/2010
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-009-0007-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Predictors and Correlates of Burnout in Residents Working With Cancer Patients

Communication Skills Training on How to Break Bad News for Japanese Nurses in Oncology: Effects of Training on Nurses’ Confidence and Perceived Effectiveness

Understanding Factors Related to Colorectal Cancer (CRC) Screening Among Urban Hispanics: Use of Focus Group Methodology

Improving Breast Cancer Education: The Case of an Evolving Multidisciplinary Module for Undergraduate Medical Students (Lausanne Medical School, 1993–2008)

Using the Values-Based History to Fine-Tune Advance Care Planning for Oncology Patients

A New Era—We Welcome Our Collaboration with Springer!

Keynote webinar | Spotlight on antibody–drug conjugates in cancer